Enliven Therapeutics to Present at Upcoming Investor Conferences
Provided By PR Newswire
Last update: May 22, 2025
BOULDER, Colo., May 22, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that management will present at the following investor conferences:
Read more at prnewswire.com
